Saa CA, Salvador AM, Guillem SJ, Saiz SC

Language: Spanish
References: 19
Page: 86-94
PDF size: 455.09 Kb.

ABSTRACT

Introduction: Smoking is one of the main causes of premature death and loss of quality of life related to health.
Objective: The purpose of this work was to explore and evaluate the answers formulated to an exam question in the knowledge acquired in myths about tobacco and its demystification after having taught an Epidemiology and Public Health practice to 344 students of 1st year Degree in Medicine (2019-2020).
Method: It was carried out in a sample of 344 students of the University of Valencia (2019-2020 academic year), who were given a practice in which some of the most popular myths about tobacco that patients frequently consult were made known. In practice, a myth from a manual was chosen, commented on and presented in pairs by free choice of the students and without repeating those already chosen. The question formulated in the exam was about exposing a myth freely and writing the answer that they would give to their patients.
Results: The most widely written group of myths was the one referring to tobacco and health myths, highlighting “quitting smoking makes you fat”. Less than 1% of the students chose the group of myths related to economics.
Conclusions: The results indicate that the knowledge about myths presented to the students can be transferred to the rest of society, making it difficult for health professionals to quit smoking. In addition, the majority of students express concern about health and image issues in relation to tobacco consumption.

REFERENCES

1. Castaño Calduch T, Hebert Jiménez C, Campo San Segundo MT, Ysa Valle M, Pons Carlos-Roca A. Tabaco de liar: una prioridad de salud pública y consumo. Gaceta Sanitaria. 2012 May 1;26(3):267-9. doi: 10.1016/j.gaceta.2011.09.010

2. Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med. 2019;380(7):629-37. doi:10.1056/NEJMoa1808779

3. Villena Ferrer A, Morena Rayo S, Párraga Martínez I, González Céspedes MD, Soriano Fernández H, López- Torres Hidalgo. Factores asociados al consumo de tabaco en adolescentes. Rev Clin Med Fam [Internet]. 2009 Jun [citado 2022 Ene 30];2(7):320-5. Disponible en: http:// scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1699- 695X2009000200002&lng=es

4. Nerín I. El fumador pasivo, ¿mito o realidad? Archivos de Bronconeumología. 2006;42:25-31.

5. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebocontrolled clinical trial. Lancet. 2016;387(10037):2507-20. doi:10.1016/S0140-6736(16)30272-0

6. Valera Fernández MR, González Cuello AM, Aceña Domínguez R, Valera Fernández AB, Moreno Poyato AR, Fonseca Casals F. Efectividad de una intervención de enfermería sobre abordaje al tabaquismo en personas con un trastorno mental. Revista Española de Enfermería de Salud Mental 2019 Dec 12;(9):3-9.

7. Córdoba R, Samitier E. 50 Mitos del tabaco. Zaragoza: Departamento de Salud y Consumo Gobierno de Aragón; 2009.

8. Ruiz Mori E, Ruiz Mori H, Salazar-Rojas R, Torres-Mallma C, Valer-Villanueva S, Santiago B, Blas-Rodriguez HJ, Vásquez Tornero C, Guevara Gonzales L. Conocimiento de los riesgos del tabaquismo en fumadores, exfumadores y no fumadores. Horizonte Médico (Lima). 2016;16(1):32-37.

9. Prochaska JO, DiClemente CC. Stages and processes of selfchange of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390-5. doi:10.1037//0022- 006x.51.3.390

10. Sakai-Bizmark R, Richmond TK, Kawachi I, et al. School Social Capital and Tobacco Experimentation Among Adolescents: Evidence From a Cross-Classified Multilevel, Longitudinal Analysis. J Adolesc Health. 2020;66(4):431-8. doi:10.1016/j.jadohealth.2019.10.022

11. Cavazos-Rehg P, Li X, Kasson E, et al. Exploring How Social Media Exposure and Interactions Are Associated With ENDS and Tobacco Use in Adolescents From the PATH Study. Nicotine Tob Res. 2021;23(3):487-94. doi:10.1093/ ntr/ntaa113

12. Grobman B, Wu R, Jackson A, et al. First tobacco product tried among adolescents based on race/ethnicity and socioeconomic status. Addict Behav. 2021;113:106666. doi:10.1016/j.addbeh.2020.106666

13. McDonald P, Maxwell T, Lawrance K. For Smokers Who Don’t Want to Quit One Step at a Time. [Internet]. Canadian Cancer Society; 2013. [citado el 10 de abril de 2021]. Disponible en: https://www.smokershelpline.ca/docs/ default-source/default-document-library/pdf/osaat-who_ dont_want_to_quit_en_nov2014.pdf?sfvrsn=74f7d3f1_0

14. Kos K. Cardiometabolic Morbidity and Mortality with Smoking Cessation, Review of Recommendations for People with Diabetes and Obesity. Curr Diab Rep. 2020;20(12):82. doi:10.1007/s11892-020-01352-6

15. Tarrazo M, Pérez-Ríos M, Santiago-Pérez MI, Malvar A, Suanzes J, Hervada X. Cambios en el consumo de tabaco: auge del tabaco de liar e introducción de los cigarrillos electrónicos. Gac Sanit. 2017;31(3):204-9. doi: 10.1016/j. gaceta.2016.06.002

16. O’Connor RJ, McNeill A, Borland R, et al. Smokers’ beliefs about the relative safety of other tobacco products: findings from the ITC collaboration. Nicotine Tob Res. 2007;9(10):1033-42. doi:10.1080/14622200701591583

17. Chapman S. “Keep a low profile”: pesticide residue, additives, and freon use in Australian tobacco manufacturing. Tob Control. 2003;12 Suppl 3(Suppl 3):iii45-iii53. doi:10.1136/ tc.12.suppl_3.iii45

18. Granda-Orive JI, Jiménez-Ruiz CA. Algunas consideraciones sobre el tabaco de liar. Arch Bronconeumol. 2011;47(9): 425-6. doi:10.1016/j.arbres.2011.02.012

19. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3: CD008286. doi:10.1002/14651858.CD008286.pub3